Zum Inhalt springen

Oxford Antibiotic Group

  • Home
  • Company
    • Management
    • Advisory board
    • Cooperation partners
    • Investors
  • Research & development
    • Innovative Discovery and Development
    • Core Facility
    • Core platforms
      • Chem-biotic platform
      • Disc-biotic platform
      • Dev-biotic platform
    • Contractual work
  • Pipeline and Programmes
    • TetramOX
    • TetramCOL
    • NeuroMETOX
    • Oxfocid
    • Library
  • Contact

Therapeutic areas

  • Antibiotic market
  • MRSA infections
  • Infective Endocarditis
  • Skin and Skin Structure Infections (SSSI)
  • Healthcare-Associated Pneumonia (HCAP)

Search

Oxford Antibiotic Group

Contact/Imprint

Create a website or blog at WordPress.com
Datenschutz & Cookies: Diese Website verwendet Cookies. Wenn du die Website weiterhin nutzt, stimmst du der Verwendung von Cookies zu.
Weitere Informationen, beispielsweise zur Kontrolle von Cookies, findest du hier: Cookie-Richtlinie